Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211081 · ClinicalTrials.gov registry record · NA
Spironolactone in Patients With Single Ventricle Heart
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00211081 is a NA study that has completed, run by Emory University. The registered enrollment target is 12 participants.
The verdict
NCT00211081, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Ultrasound is a technique that can provide images of the blood vessels such as arteries. The size of the arteries, such as the main blood vessel in the arm, can change under different conditions. Using ultrasound we can see how arteries change with movement or even drugs. We want to use ultrasound to see how blood vessels look in patients with Congestive Heart Failure (CHF) and to also see how a drug called Spironolactone, commonly prescribed for patients with this disease, effects blood vessel function in patients with congestive heart failure. This information may be used to change the standard of care for patients with heart failure especially if we show that Spironolactone has a positive effect on vessel function in patients with CHF.
Interventions
- DRUG Spironolactone (drug)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-11 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211081
The ClinicalTrials.gov registry entry for NCT00211081 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spironolactone (drug) is the first listed.
NCT00211081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211081 about?
NCT00211081 is a clinical study titled "Spironolactone in Patients With Single Ventricle Heart". Ultrasound is a technique that can provide images of the blood vessels such as arteries. The size of the arteries, such as the main blood vessel in the arm, can change under different conditions. Using ultrasound we can see how arteries change with movement or even drugs. We want to use ultrasound t...
What is the current status of trial NCT00211081?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2004-11. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00211081?
The interventions under investigation include: Spironolactone (drug) (DRUG).
Who is sponsoring clinical trial NCT00211081?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.